Therapeutische vitrektomie bei uveitis. Aktueller stand und empfehlungen

Translated title of the contribution: Therapeutic vitrectomy in uveitis. Current status and recommendations

M. D. Becker, N. Harsch, M. Zierhut, Janet L Davis, F. G. Holz

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

With the advent of modern vitreoretinal surgical techniques, the spectrum for surgical intervention in various forms of uveitis has been notably expanded. Removal of optically relevant vitreous opacities, improvement of secondary macular edema, delamination of epiretinal membranes, and release of traction in the presence of abnormal vitreoretinal adhesions represent indications for vitreoretinal procedures in uveitis patients. Furthermore, retinal and choroidal biopsies may be obtained if the precise etiology is unknown. This in turn offers the opportunity to better target pharmacological interventions. Combined cataract surgery or intravitreal implantation of drug devices may also be of therapeutic benefit. So far no prospective, controlled clinical trials have been performed to precisely evaluate the role of pars plana vitrectomy (ppV) as a single or combined surgical procedure in patients with intraocular inflammation. Inconsistent data exist regarding prognostic determinants and the role of perioperative immunosuppression. Here, the current knowledge on the subject is reviewed and critically discussed, and recommendations for patient management are given. Further studies are needed.

Original languageGerman
Pages (from-to)787-795
Number of pages9
JournalOphthalmologe
Volume100
Issue number10
DOIs
StatePublished - Oct 1 2003
Externally publishedYes

Fingerprint

Vitrectomy
Uveitis
Epiretinal Membrane
Temazepam
Macular Edema
Controlled Clinical Trials
Traction
Immunosuppression
Cataract
Therapeutics
Pharmacology
Inflammation
Biopsy
Equipment and Supplies
Pharmaceutical Preparations

Keywords

  • Immunosuppression
  • Intraocular inflammation
  • Macular edema
  • Pars plana vitrectomy
  • Vitreous opacities

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Therapeutische vitrektomie bei uveitis. Aktueller stand und empfehlungen. / Becker, M. D.; Harsch, N.; Zierhut, M.; Davis, Janet L; Holz, F. G.

In: Ophthalmologe, Vol. 100, No. 10, 01.10.2003, p. 787-795.

Research output: Contribution to journalArticle

Becker, M. D. ; Harsch, N. ; Zierhut, M. ; Davis, Janet L ; Holz, F. G. / Therapeutische vitrektomie bei uveitis. Aktueller stand und empfehlungen. In: Ophthalmologe. 2003 ; Vol. 100, No. 10. pp. 787-795.
@article{eefdee70c281413da0861c75dffb0da9,
title = "Therapeutische vitrektomie bei uveitis. Aktueller stand und empfehlungen",
abstract = "With the advent of modern vitreoretinal surgical techniques, the spectrum for surgical intervention in various forms of uveitis has been notably expanded. Removal of optically relevant vitreous opacities, improvement of secondary macular edema, delamination of epiretinal membranes, and release of traction in the presence of abnormal vitreoretinal adhesions represent indications for vitreoretinal procedures in uveitis patients. Furthermore, retinal and choroidal biopsies may be obtained if the precise etiology is unknown. This in turn offers the opportunity to better target pharmacological interventions. Combined cataract surgery or intravitreal implantation of drug devices may also be of therapeutic benefit. So far no prospective, controlled clinical trials have been performed to precisely evaluate the role of pars plana vitrectomy (ppV) as a single or combined surgical procedure in patients with intraocular inflammation. Inconsistent data exist regarding prognostic determinants and the role of perioperative immunosuppression. Here, the current knowledge on the subject is reviewed and critically discussed, and recommendations for patient management are given. Further studies are needed.",
keywords = "Immunosuppression, Intraocular inflammation, Macular edema, Pars plana vitrectomy, Vitreous opacities",
author = "Becker, {M. D.} and N. Harsch and M. Zierhut and Davis, {Janet L} and Holz, {F. G.}",
year = "2003",
month = "10",
day = "1",
doi = "10.1007/s00347-003-0918-8",
language = "German",
volume = "100",
pages = "787--795",
journal = "Der Ophthalmologe",
issn = "0941-293X",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Therapeutische vitrektomie bei uveitis. Aktueller stand und empfehlungen

AU - Becker, M. D.

AU - Harsch, N.

AU - Zierhut, M.

AU - Davis, Janet L

AU - Holz, F. G.

PY - 2003/10/1

Y1 - 2003/10/1

N2 - With the advent of modern vitreoretinal surgical techniques, the spectrum for surgical intervention in various forms of uveitis has been notably expanded. Removal of optically relevant vitreous opacities, improvement of secondary macular edema, delamination of epiretinal membranes, and release of traction in the presence of abnormal vitreoretinal adhesions represent indications for vitreoretinal procedures in uveitis patients. Furthermore, retinal and choroidal biopsies may be obtained if the precise etiology is unknown. This in turn offers the opportunity to better target pharmacological interventions. Combined cataract surgery or intravitreal implantation of drug devices may also be of therapeutic benefit. So far no prospective, controlled clinical trials have been performed to precisely evaluate the role of pars plana vitrectomy (ppV) as a single or combined surgical procedure in patients with intraocular inflammation. Inconsistent data exist regarding prognostic determinants and the role of perioperative immunosuppression. Here, the current knowledge on the subject is reviewed and critically discussed, and recommendations for patient management are given. Further studies are needed.

AB - With the advent of modern vitreoretinal surgical techniques, the spectrum for surgical intervention in various forms of uveitis has been notably expanded. Removal of optically relevant vitreous opacities, improvement of secondary macular edema, delamination of epiretinal membranes, and release of traction in the presence of abnormal vitreoretinal adhesions represent indications for vitreoretinal procedures in uveitis patients. Furthermore, retinal and choroidal biopsies may be obtained if the precise etiology is unknown. This in turn offers the opportunity to better target pharmacological interventions. Combined cataract surgery or intravitreal implantation of drug devices may also be of therapeutic benefit. So far no prospective, controlled clinical trials have been performed to precisely evaluate the role of pars plana vitrectomy (ppV) as a single or combined surgical procedure in patients with intraocular inflammation. Inconsistent data exist regarding prognostic determinants and the role of perioperative immunosuppression. Here, the current knowledge on the subject is reviewed and critically discussed, and recommendations for patient management are given. Further studies are needed.

KW - Immunosuppression

KW - Intraocular inflammation

KW - Macular edema

KW - Pars plana vitrectomy

KW - Vitreous opacities

UR - http://www.scopus.com/inward/record.url?scp=0242355119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242355119&partnerID=8YFLogxK

U2 - 10.1007/s00347-003-0918-8

DO - 10.1007/s00347-003-0918-8

M3 - Article

C2 - 14618350

AN - SCOPUS:0242355119

VL - 100

SP - 787

EP - 795

JO - Der Ophthalmologe

JF - Der Ophthalmologe

SN - 0941-293X

IS - 10

ER -